Associated Papers
Influence of the IDOL Gene Variants on Low-Density Lipoprotein Cholesterol Levels in Turkish Patients with Familial Hypercholesterolemia.
Duymus F et al.
Molecular Syndromology, 2025
A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease.
Kalwick M et al.
Nutrients, 2025
Pharmacogenomics of statins: lipid response and other outcomes in Brazilian cohorts.
Dagli-Hernandez C et al.
Pharmacological Reports : Pr, 2022
Genetic Determinants of Plasma Low-Density Lipoprotein Cholesterol Levels: Monogenicity, Polygenicity, and "Missing" Heritability.
Martín-Campos JM
Biomedicines, 2021
Genetic polymorphism of IDOL gene was associated with the susceptibility of coronary artery disease in Han population in Xinjiang, China.
Adi D et al.
Hereditas, 2021
IDOL G51S Variant Is Associated With High Blood Cholesterol and Increases Low-Density Lipoprotein Receptor Degradation.
Adi D et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2019
Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.
Calender A et al.
Bmc Medical Genomics, 2018
Exome chip meta-analysis identifies novel loci and East Asian-specific coding variants that contribute to lipid levels and coronary artery disease.
Lu X et al.
Nature Genetics, 2017
A powerful statistical framework for generalization testing in GWAS, with application to the HCHS/SOL.
Sofer T et al.
Genetic Epidemiology, 2017
IDOL, inducible degrader of low-density lipoprotein receptor, serves as a potential therapeutic target for dyslipidemia.
Zhang CP et al.
Medical Hypotheses, 2016
Novel genes in LDL metabolism--a comprehensive overview.
Christoffersen M et al.
Current Opinion in Lipidology, 2015
Identification of HPV integration and gene mutation in HeLa cell line by integrated analysis of RNA-Seq and MS/MS data.
Sun H et al.
Journal of Proteome Research, 2015
IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population.
Dhyani A et al.
Plos One, 2015
The eSNV-detect: a computational system to identify expressed single nucleotide variants from transcriptome sequencing data.
Tang X et al.
Nucleic Acids Research, 2014
The MYLIP p.N342S polymorphism is associated with response to lipid-lowering therapy in Brazilian patients with familial hypercholesterolemia.
Santos PC et al.
Pharmacogenetics and Genomics, 2014
Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.
Szeto CY et al.
Febs Open Bio, 2014
Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein.
Sorrentino V et al.
European Heart Journal, 2013
Contribution of common genetic variation to the risk of type 2 diabetes in the Mexican Mestizo population.
Gamboa-Meléndez MA et al.
Diabetes, 2012
Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis.
Zhang L et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2012
Association of MYLIP rs3757354 SNP and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Yan TT et al.
Lipids in Health and Disease, 2012
MYLIP p.N342S polymorphism is not associated with lipid profile in the Brazilian population.
Santos PC et al.
Lipids in Health and Disease, 2012
Post-transcriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor.
Sorrentino V et al.
Current Opinion in Lipidology, 2012
The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans.
Weissglas-Volkov D et al.
The Journal of Clinical Investigation, 2011
Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.
Ryu GM et al.
Nucleic Acids Research, 2009
Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.
Girona J et al.
Journal of Clinical Lipidology, 0
SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.
Wang JQ et al.
The Journal of Biological Chemistry, 0